Ritter Pharmaceuticals IPO Research Information

Ritter Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Ritter Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Ritter Pharmaceuticals	RTTR - NASDAQ	$5.00-$5.00	$5.00	$5.00	4 million	6/24/2015
Underwriter(s): Aegis Capital Corp, Chardan Capital Markets
Co-Manager(s): Barrington Research
Industry: Health Care
Filing(s): Filed 2015-03-23 Terms Added 2015-04-24 Amended Terms 2015-06-19

Ritter Pharmaceuticals Quote & Chart - Click for current quote - RTTR

About Ritter Pharmaceuticals (adapted from Ritter Pharmaceuticals prospectus):
They develop novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases.

This description is adapted from Ritter Pharmaceuticals-RTTR prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Ritter Pharmaceuticals-RTTR "RTTR" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.